Protection of organophosphate-inactivated esterases with phosphotriesterase

Fundamental and Applied Toxicology

Volumn 31, Issue 2, 1996, Pages 210-217

  Tuovinen, Kai ^a   Kaliste Korhonen, Eila ^a   Raushel, Frank M ^b   Hänninen, Osmo ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b TEXAS A AND M UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOXYLESTERASE; CHOLINESTERASE; DYFLOS; ENZYME; ORGANOPHOSPHATE; PARAOXON; PHOSPHOTRIESTERASE; SARIN; SOMAN; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN; CHOLINESTERASE INHIBITION; CONTROLLED STUDY; ENZYME INHIBITION; ERYTHROCYTE; INTOXICATION; INTRAVENOUS DRUG ADMINISTRATION; ISOTOPE LABELING; LUNG; MALE; MOUSE; NONHUMAN; PLASMA;

ANIMALIA;

EID: 26844554200     PISSN: 02720590     EISSN: None     Source Type: Journal    
DOI: 10.1006/faat.1996.0093     Document Type: Article

References (24)

1. Ashani, Y., Shapira, S., Levy, D., Wolfe, A. D., Doctor, B. P., and Raveh, L. (1991). Butyrylcholinesterase and acetylcholinesterase prophylaxis against soman poisoning in mice. Biochem. Pharmacol 41, 37-41.
2. Ashani, Y. (1992). Protection against tabun toxicity in mice by prophylaxis with an enzyme hydrolyzing organophosphate esters. Biochem. Pharmacol. 44, 397-400.
3. Augustinsson, K. B., Eriksson, H., and Faijersson, Y. (1978). A new approach to determining cholinesterase activities in samples of whole blood. Clin. Chim. Acta 89, 239-252.
4. De Jong, L. P. A., and Wolring, G. Z. (1984). Stereospecific reactivation by some Hagedorn oximes of acetylcholinesterases from various species including man, inhibited by soman. Biochem. Pharmacol. 33, 1119-1125.
5. Dumas, D. P., Wild, J. R., and Raushel, F. M. (1989a). Diisopropylfluorophosphate hydrolysis by a phosphotriesterase from Pseudomonas diminuta. Biotech. Appl. Biochem. 11, 235-243.
6. Dumas, D. P., Caldwell, S. R., Wild, J. R., and Raushel, F. M. (1989b). Purification and properties of the phosphotriesterase from Pseudomonas diminuta. J. Biol. Chem. 264, 19659-19665.
7. Dumas, D. P., Durst, H. D., Landis, W. G., Raushel, F. M., and Wild, J. R. (1990). Inactivation of organophosphorus nerve agents by the phosphotriesterase from Pseudomonas diminuta. Arch. Biochem. Biophys. 277, 155-159.
8. Dunn, M. A., and Sidell, F. R. (1989). Progress in medical defense against nerve agents. JAMA 262, 649-652.
9. Ellman, G. L., Courtney, K. D., Andres, V., Jr., and Featherstone, R. M. (1961). A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 7, 88-95.
10. Kaliste-Korhonen, E., Ylitalo, P., Hänninen, O., and Raushel, F. M. (1993). Phosphotriesterase decreases paraoxon toxicity in mice. Toxicol. Appl. Pharmacol. 121, 275-278.
11. Krisch, K. (1966). Reaction of a microsomal esterase from hog-liver with diethyl p-nitrophenyl phosphate. Biochim. Biophys. Acta 122, 265-280.
12. Lowry, O. H., Rosebrough, N. J., Farr, A. L., and Randall, R. J. (1951). Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193, 265-275.
13. Markwell, M. A. K. (1982). A new solid-state reagent to iodinate proteins. Anal. Biochem. 125, 427-432.
14. Maxwell, D. M. (1992). The specificity of carboxylesterase protection against the toxicity of organophosphorus compounds. Toxicol. Appl. Pharmacol 114, 306-312.
15. Omburo, G. A., Kuo, J. A., Mullins, L. S., and Raushel, F. M. (1992). Characterization of the zinc binding site of bacterial phosphotriesterase. J. Biol. Chem. 267, 13278-13283.
16. Pei, L., Omburo, G., McGuinn, W. D., Petrikovics, I., Dave, K., Raushel, F. M., Wild, J. R., and DeLoach, J. R. (1994). Encapsulation of phosphotriesterase within murine erythrocytes. Toxicol. Appl. Pharmacol. 124, 296-301.
17. Sket, D., and Brzin, M. (1986). Effect of HI-6, applied into the cerebral ventricles on the inhibition of brain acetylcholinesterase by soman in rats. Neuropharmacology 25, 103-107.
18. Tuovinen, K., Kaliste-Korhonen, E., Raushel, F. M., and Hänninen, O. (1994). Phosphotriesterase - A promising candidate for use in detoxification of organophosphates. Fundam. Appl. Toxicol. 23, 578-584.
19. Van Dongen, C. J., Elskamp, R. M., and De Jong, L. P. A. (1987). Influence of atropine upon reactivation and aging of rat and human erythrocyte acetylcholinesterase inhibited by soman. Biochem. Pharmacol. 36,1167-1169.
20. Wang, C. S., and Kloer, H. U. (1983). Kinetic properties of human pancreatic carboxylesterase. Biochim. Biophys. Acta 754, 142-149.
21. Wolfe, A. D., Rush, R. S., Doctor, B. P., Koplovitz, I., and Jones, D. (1987). Acetylcholinesterase prophylaxis against organophosphate toxicity. Fundam. Appl. Toxicol 9, 266-270.
22. Wolfe, A. D., Maxwell, D. M., Raveh, L., Ashani, Y., and Doctor, B. P. (1991). In vivo detoxification of organophosphate in marmosets by acetylcholinesterase. In Proceedings of the 1991 Medical Defense Bioscience Review, pp. 547-550. Edgewood, MD.
23. Wolfe, A. D., Blick, D. W., Murphy, M. R., Miller, S. A., Gentry, M. K., Hartgraves, S. L., and Doctor, B. P. (1992). Use of cholinesterase as pretreatment drugs for the protection of rhesus monkeys against soman toxicity. Toxicol Appl Pharmacol 117, 189-193.
24. Zemaitis, M. A., and Greene, F. E. (1976). Impairment of hepatic microsomal and plasma esterases of the rat by disulfiram and diethyldithiocarbamate. Biochem. Pharmacol. 25, 453-459.